Scorpius Holdings, Inc. (SCPXD)
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.
Address
627 DAVIS DRIVE
MORRISVILLE, NC 27560
Founded
2008
Number of Employees
84
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)